125 related articles for article (PubMed ID: 3620716)
21. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
22. The Auckland Breast Cancer Register: a special project of the Auckland Breast Cancer Study Group.
Neave L; Harvey V; Benjamin C; Thompson P; Pellett O; Whitlock J; Jones W; Poole G;
N Z Med J; 2003 Oct; 116(1184):U648. PubMed ID: 14583806
[TBL] [Abstract][Full Text] [Related]
23. Body mass index and clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer.
Gevorgyan A; Bregni G; Galli G; Ganzinelli M; Martinetti A; Lo Vullo S; Mariani L; Festinese F; Sottotetti E; de Braud F; Di Cosimo S
Tumori; 2016 Aug; 102(4):e11-4. PubMed ID: 27174629
[TBL] [Abstract][Full Text] [Related]
24. Hormone receptors and obesity in Japanese women with breast cancer.
Kuno K; Fukami A; Hori M; Kasumi F
Breast Cancer Res Treat; 1981; 1(2):135-9. PubMed ID: 7348570
[TBL] [Abstract][Full Text] [Related]
25. Effects of obesity on presentation of breast cancer, lymph node metastasis and patient survival: a retrospective review.
Kaviani A; Neishaboury M; Mohammadzadeh N; Ansari-Damavandi M; Jamei K
Asian Pac J Cancer Prev; 2013; 14(4):2225-9. PubMed ID: 23725117
[TBL] [Abstract][Full Text] [Related]
26. Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan).
Yoo K; Tajima K; Park S; Kang D; Kim S; Hirose K; Takeuchi T; Miura S
Cancer Lett; 2001 Jun; 167(1):57-63. PubMed ID: 11323099
[TBL] [Abstract][Full Text] [Related]
27. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
28. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
29. Relationship of presence of progesterone receptors to prognosis in early breast cancer.
Pichon MF; Pallud C; Brunet M; Milgrom E
Cancer Res; 1980 Sep; 40(9):3357-60. PubMed ID: 7427948
[TBL] [Abstract][Full Text] [Related]
30. The effect of obesity on recurrence pattern in early breast cancer patients.
Yazici O; Aksoy S; Sendur MA; Babacan T; Ozdemir N; Ozisik Y; Zengin N; Altundag K
J BUON; 2015; 20(4):954-62. PubMed ID: 26416043
[TBL] [Abstract][Full Text] [Related]
31. Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study.
Montazeri A; Sadighi J; Farzadi F; Maftoon F; Vahdaninia M; Ansari M; Sajadian A; Ebrahimi M; Haghighat S; Harirchi I
BMC Cancer; 2008 Sep; 8():278. PubMed ID: 18826621
[TBL] [Abstract][Full Text] [Related]
32. The influence of young age on outcome in early stage breast cancer.
Fowble BL; Schultz DJ; Overmoyer B; Solin LJ; Fox K; Jardines L; Orel S; Glick JH
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):23-33. PubMed ID: 8083119
[TBL] [Abstract][Full Text] [Related]
33. Abstracting height and weight from medical records, and breast cancer pathologic factors.
McEligot AJ; Im T; Dillman RO; West JG; Salem R; Haque R; Anton-Culver H
Cancer Causes Control; 2008 Dec; 19(10):1217-26. PubMed ID: 18618281
[TBL] [Abstract][Full Text] [Related]
34. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
[TBL] [Abstract][Full Text] [Related]
35. Obesity is associated with a poorer prognosis in women with hormone receptor positive breast cancer.
Robinson PJ; Bell RJ; Davis SR
Maturitas; 2014 Nov; 79(3):279-86. PubMed ID: 25088248
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
37. Impact of obesity on diagnosis and treatment of breast cancer.
Deglise C; Bouchardy C; Burri M; Usel M; Neyroud-Caspar I; Vlastos G; Chappuis PO; Ceschi M; Ess S; Castiglione M; Rapiti E; Verkooijen HM
Breast Cancer Res Treat; 2010 Feb; 120(1):185-93. PubMed ID: 19597985
[TBL] [Abstract][Full Text] [Related]
38. Impact of the obesity on lymph node status in operable breast cancer patients.
Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Solak M; Turkoz FP; Arik Z; Esin E; Petekkaya I; Altundag K
J BUON; 2013; 18(4):824-30. PubMed ID: 24344004
[TBL] [Abstract][Full Text] [Related]
39. Larger axillary metastases in obese women and smokers with breast cancer--an influence by host factors on early tumor behavior.
Daniell HW; Tam E; Filice A
Breast Cancer Res Treat; 1993; 25(3):193-201. PubMed ID: 8369520
[TBL] [Abstract][Full Text] [Related]
40. Recurrence of breast cancer. Obesity, tumor size, and axillary lymph node metastases.
Sohrabi A; Sandoz J; Spratt JS; Polk HC
JAMA; 1980 Jul; 244(3):264-5. PubMed ID: 7382092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
